3,7,8,9 This study is not a recommendation for a particular treatment but rather an observational analysis of available data for patients prescribed semaglutide
"We have observed remarkable improvements in some lymphedema patients taking GLP-1 receptor agonists, but there is no prospective data to confirm these effects," said Dr
A section reserved for HealthVerity Marketplace data illustrates the richness of real-world evidence available to inform strategic decisions
Tirzepatide showed a noninferior reduction in all-cause mortality (HR 0.88, 95% CI 0.68 to 1.16), myocardial infarction (HR 0.91, 95% CI 0.73 to 1.12) and stroke (HR 0.78, 95% CI 0.59 to 1.03) compared to dulaglutide, although CIs remained compatible with no difference
Weight-Loss Pill Metformin ($99/month): oral Metformin, not a GLP-1